News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Daily News Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF L.A. McKeown November 02, 2018
Presentation TCT Abstracts Posters 2018 Long Term Outcomes of Melody Valve-in-valve Implantation for Bioprosthetic Mitral Valve Dysfunction Presenter: Timothy A. Joseph September 25, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights Shelley Wood September 23, 2018
News Daily News TCT 2018 High Mortality but Durable Results With Valve-in-Valve TAVR Michael O'Riordan September 23, 2018
Presentation TCT 2018 PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve Presenter: John G. Webb September 23, 2018
Presentation TCT 2018 Case Presentation: A TR Case of Bioprosthetic Valve Failure Presenter: Torsten Vahl September 23, 2018
Presentation TCT 2018 #6 The Russian Doll Approach Severe AS/AR With Bioprosthetic Valve Failure and Complex Anatomy - Case Presentation Presenter: Amisha Patel September 22, 2018
Presentation TCT 2018 Case #4: Bioprosthetic Valve Fracture - Before or After TAVR ViV? Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré September 22, 2018
Presentation TCT 2018 Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré September 22, 2018
Presentation TCT 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas September 22, 2018
Presentation TCT 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno September 22, 2018
Presentation TCT 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard September 22, 2018
Presentation TCT 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum September 22, 2018
Presentation TCT 2018 To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla September 22, 2018
Presentation TCT 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke September 22, 2018
Presentation TCT 2018 Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb September 22, 2018
Presentation TCT 2018 Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA) Presenter: Jaffar M Khan September 21, 2018
News Conference News ESC 2018 Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI Michael O'Riordan August 25, 2018
News Daily News Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data L.A. McKeown July 31, 2018